About Us
Mr. Tan Zheng (Chairman, Executive Director)
Mainly responsible for the overall strategic planning and business development direction of the group. Mr. Tan has over twenty years of experience in the Chinese pharmaceutical industry, with rich experience in corporate operations and management, as well as extensive resources within the industry and society.
Mr. Zhang Jian (Senior Vice President)
Mainly responsible for the administrative services related to the group. Mr. Zhang Jian has over twenty years of experience in the pharmaceutical and health industry, having held senior management positions in several pharmaceutical and medical technology companies, with a deep understanding of the industry and rich management experience.
Dr. Huaizhong Hu (Chief Scientist)
Dr. Huaizhong Hu is a renowned expert in immunology and toxicology. He obtained his Doctor of Medicine from West China University of Medical Sciences and Doctor of Philosophy in Immunology from Utrecht University in the Netherlands, and completed his postdoctoral research at the National Institutes of Health (NIH) in the United States. He holds the Diplomate of the American Board of Toxicology (DABT) certification, and is a member of both the American Association of Immunologists and the Society of Toxicology. He has been selected for Beijing’s Overseas High-Level Talent Program and Chaoyang District’s Phoenix Talent Program. Currently, Dr. Hu serves as a Standing Committee Member of the Biotechnological Drug Professional Committee and the Immunotoxicology Professional Committee of the Chinese Society of Toxicology. As the Chief Scientific Officer of Beijing Immunotech Biopharm, he boasts profound expertise in innovative drug research and development as well as clinical trials, with a particular focus on the T cell therapy field. He has successfully developed and commercialized a number of innovative biologics targeting T cells and in vitro diagnostic kits. Dr. Hu has published over 60 research articles in peer-reviewed biomedical journals and holds over 20 invention patents. His extensive research experience and outstanding academic achievements will strengthen the rapid development of Immunotech Biopharm in the field of immune cell therapy.